ID   GC-BJAB
AC   CVCL_5758
SY   Genome Containing-BJAB; BJAB-B95.8
DR   cancercelllines; CVCL_5758
DR   Wikidata; Q54835485
RX   PubMed=62724;
RX   PubMed=170210;
RX   PubMed=171663;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=170210).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=62724; DOI=10.1002/ijc.2910180513;
RA   Klein G., Zeuthen J., Terasaki P.I., Billing R.J., Honig R., Jondal M.,
RA   Westman A., Clements G.B.;
RT   "Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker
RT   properties of EBV-negative lymphoma lines and their in vitro
RT   EBV-converted sublines.";
RL   Int. J. Cancer 18:639-652(1976).
//
RX   PubMed=170210; DOI=10.1002/ijc.2910160114;
RA   Clements G.B., Klein G., Povey S.;
RT   "Production by EBV infection of an EBNA-positive subline from an
RT   EBNA-negative human lymphoma cell line without detectable EBV DNA.";
RL   Int. J. Cancer 16:125-133(1975).
//
RX   PubMed=171663; DOI=10.1073/pnas.72.9.3518;
RA   Steinitz M., Klein G.;
RT   "Comparison between growth characteristics of an Epstein-Barr virus
RT   (EBV)-genome-negative lymphoma line and its EBV-converted subline in
RT   vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 72:3518-3520(1975).
//